Advertisement
Screener

METAVIA INC. (MTVA) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

METAVIA INC. Shares Authorized

METAVIA INC. (MTVA) had Shares Authorized of 100.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-06

  • 2026-06-30: Common Stock, Shares Authorized 100.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 100.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 100.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 100.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-30100.00M shares
10-Q · filed 2026-08-06
2026-03-31100.00M shares
10-Q · filed 2026-05-14
2025-12-31100.00M shares
10-Q · filed 2026-08-06
2025-09-30100.00M shares
10-Q · filed 2025-11-06
2025-06-30100.00M shares
10-Q · filed 2025-08-07
2025-03-31100.00M shares
10-Q · filed 2025-05-14
2024-12-31100.00M shares
10-K · filed 2026-03-26
2024-09-30100.00M shares
10-Q · filed 2024-11-07
2024-06-30100.00M shares
10-Q · filed 2024-08-14
2024-03-31100.00M shares
10-Q · filed 2024-05-09
2023-12-31100.00M shares
10-K · filed 2025-03-20
2023-09-30100.00M shares
10-Q · filed 2023-11-13
2023-06-30100.00M shares
10-Q · filed 2023-08-09
2023-03-31100.00M shares
10-Q · filed 2023-05-12
2022-12-31100.00M shares
10-K · filed 2024-03-28
2022-09-30100.00M shares
10-Q · filed 2022-11-14
2022-06-30100.00M shares
10-Q · filed 2022-08-12
2022-03-31100.00M shares
10-Q · filed 2022-05-13
2021-12-31100.00M shares
10-K · filed 2023-03-30
2021-09-30100.00M shares
10-Q · filed 2021-11-15
2021-06-30100.00M shares
10-Q · filed 2021-08-16
2021-03-31100.00M shares
10-Q · filed 2021-05-17
2020-12-31100.00M shares
10-K · filed 2022-03-31
2020-09-30100.00M shares
10-Q · filed 2020-11-13
2020-06-30100.00M shares
10-Q · filed 2020-08-11
2020-03-31100.00M shares
10-Q · filed 2020-05-20
2019-12-31100.00M shares
10-K · filed 2021-04-15
2019-09-30100.00M shares
10-Q · filed 2019-11-08
2019-06-30100.00M shares
10-Q · filed 2019-08-09
2019-03-31100.00M shares
10-Q · filed 2019-05-09
2018-12-3145.80M shares
10-K · filed 2020-03-30
100.00M shares
10-K · filed 2019-03-18
2018-09-30100.00M shares
10-Q · filed 2018-11-08
2018-06-30100.00M shares
10-Q · filed 2018-08-14
2018-03-31100.00M shares
10-Q · filed 2018-05-08
2017-12-31100.00M shares
10-K · filed 2019-03-18
2017-09-30100.00M shares
10-Q · filed 2017-11-13
2017-06-30100.00M shares
10-Q · filed 2017-08-14
2017-03-31100.00M shares
10-Q · filed 2017-05-10
2016-12-31100.00M shares
10-K · filed 2018-03-20
2016-09-30100.00M shares
10-Q · filed 2016-11-02
2016-08-03100.00M shares
10-K · filed 2019-03-18
2016-06-3017.67M shares
10-Q · filed 2016-09-14
2015-12-3117.67M shares
10-K · filed 2017-03-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Dare Bioscience, Inc. (DARE)United States$0.011B
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92